Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05299229 · ClinicalTrials.gov registry record
Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff Measurements
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 12
- Enrollment target
NCT05299229 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 12 participants.
The verdict
NCT05299229 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the feasibility and accuracy of two methods of non-invasive hemodynamic assessments - bioreactance as assessed by non-invasive cardiac output monitoring (NICOM; Cheetah Medical) and pulse wave analysis as assessed by finger cuff arterial pressure (ClearSite, Edwards Life Sciences) - compared to hemodynamic assessments by intermittent echocardiography in early onset preeclampsia.
Interventions
- DIAGNOSTIC_TEST Echocardiogrpahy and non-invasive monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-12-29 |
| Est. Completion | 2021-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05299229
The ClinicalTrials.gov registry entry for NCT05299229 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Echocardiogrpahy and non-invasive monitoring is the first listed.
NCT05299229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05299229 about?
NCT05299229 is a clinical study titled "Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff Measurements". The purpose of this study is to compare the feasibility and accuracy of two methods of non-invasive hemodynamic assessments - bioreactance as assessed by non-invasive cardiac output monitoring (NICOM; Cheetah Medical) and pulse wave analysis as assessed by finger cuff arterial pressure (ClearSite, E...
What is the current status of trial NCT05299229?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2020-12-29. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT05299229?
The interventions under investigation include: Echocardiogrpahy and non-invasive monitoring (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05299229?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.